GlaxoSmithKline announced a recall of 13 lots of Bactroban (mupirocin) Nasal Ointment, Bactroban Ointment, and Bactroban Cream. This recall is a precautionary measure due to potential contamination during manufacturing.
Bactroban Nasal Ointment, an antibacterial, is indicated for the eradication of nasal colonization of methicillin-resistant S. aureus (MRSA) in adult patients and healthcare workers in certain institutional settings during outbreaks of infections with MRSA. Bactroban Ointment is indicated to treat impetigo due to S. pyogenes or S. aureus. Bactroban Cream is indicated to treat secondarily-infected traumatic skin lesion due to susceptible strains of S. aureus or S. pyogenes.
The affected products were distributed between October 2014 and May 2016. The recalled products are as follows:
- Bactroban Nasal Ointment 10 x 1g Tubes: Lot #C686801, #C689267, #C692405, #C698116, #C750793, #C750794, #C752166, #C752805, #C754828
- Bactroban Ointment 22g Tube: Lot #C715275
- Bactroban Cream 15g Tube: Lot #C725860, #C740904
- Bactroban Cream 30g Tube: Lot #C740906
Anyone in possession of the recalled lots are to stop distributing and quarantine them.
For more information call (888) 731-7954 or visit GSK.com.